| 발표일자: |
2018년 11월 2일(금) ~ 11월 4(일) |
| 발표번호: |
P(e-poster)-161 |
| 발표장소: |
코엑스 컨퍼런스룸 3층 301 A-B |
|
|
| 스마일수술 후 발생한 중심성 독성 각막병증 1예 |
| 1 건양대학교 의과대학 김안과병원 안과학교실 명곡안연구소
2 연세대학교 의과대학 안과학교실 |
| 고경민¹, 전익현², 김태임², 김응권², 서경률² |
| 본문 : A 35-year-old man presented with a 2-month history of decreased vision in the right eye. He had undergone small-incision lenticule extraction (SMILE) surgery 7 months earlier. Preoperatively, his central corneal thickness was 565 μm. Seven months postoperatively, examination revealed the typical central toxic keratopathy triad of corneal thinning, hyperopic shift, and a reduction in best-corrected visual acuity to 20/50. Manifest refraction in his right eye was +4.00 sph -0.75 cyl × 90 and the central corneal thickness was 373 μm. SMILE has been considered as an alternative to conventional laser in-situ keratomileusis because of its benefits of reduced denervation, less risk of dry eye postoperatively, and no flap-related complications. However, SMILE may cause central toxic keratopathy even though the incision required is small. Given the increasing use of SMILE, we believe that all refractive surgeons should be aware of this rare complication |
| |